Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Alkermes' Richard Pops

Alkermes aims to take the next biotech step

December 3, 2015 Medical Communications, Research and Development Alkermes

“We think we can be the next Biogen, or a Celgene or a Vertex – we have that much firepower …
Feature

NICE turns down bone disorder drug for NHS

December 3, 2015 Research and Development Alexion, NICE, Strensiq

NICE has published draft guidance as part of its highly specialised technologies programme, not recommending Alexion Pharma’s Strensiq (asfotase alfa) …
News
Propeller Health smart inhaler

GSK collaborates on ‘smart inhaler’ technology for respiratory trials

December 3, 2015 Research and Development COPD, GSK, Propeller, Propeller Health, asthma, clinical trials, ellipta, inhalers, smart drugs, smart inhalers

GSK has entered the ‘smart drug’ industry by partnering with a health technology company to develop a sensor for use …
News
gsk_logo_with_text

GSK gets European approval for asthma treatment Nucala

December 3, 2015 Research and Development GSK, Nucala, asthma

GlaxoSmithKline has received marketing authorisation from the European Commission for Nucala as an add-on treatment for severe refractory eosinophilic asthma …
News
mbeya_microscopy

Janssen in new collaboration to take on TB

December 3, 2015 Research and Development FIND, Janssen, antibiotic resistance, tuberculosis

Janssen has announced a new collaboration with the non-profit organisation FIND to step-up the fight against the public health threat …
News
zafgen_logo

Second patient dies in Zafgen obesity trial

December 3, 2015 Research and Development

Zafgen has announced the death of a second participant in a Phase III clinical trial of its obesity drug beloranib …
News
Victoza

Novo Nordisk buys Xoma diabetes program and scores trial successes

December 2, 2015 Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, SGLT2 inhibitors, Victoza, Xoma, diabetes

Novo Nordisk has announced its purchase of a type 2 diabetes diabetes program in a deal with biotech firm Xoma …
News
EU flags

Horizon receives European go-ahead for Ravicti

December 2, 2015 Research and Development, Sales and Marketing Horizon Pharma, Ravicti, horizon, orphan drug, rare disease, urea cycle disorders

The European Commission has approved Ravicti for rare urea cycle disorders.  Ravicti, (glycerol phenylbutyrate), is an oral liquid developed by Horizon …
News

Personalised care key to diabetes management, says NICE

December 2, 2015 Research and Development NICE, NICE guidelines, diabetes, type 2 diabetes

UK drugs regulator NICE has published updated guidelines on type 2 diabetes, saying that taking an individualised approach to care …
News
Xalkori

Pfizer lung cancer treatment gets expanded EU approval

December 1, 2015 Research and Development, Sales and Marketing NSCLC, Pfizer, Xalkori, crizotinib, lung cancer, non-small cell lung cancer

Pfizer UK has received European Commission approval for a label update to expand use of Xalkori (crizotinib) to first-line treatment …
News
janssen_scientists

J&J announces new partnerships in fight against HIV/AIDS

December 1, 2015 Research and Development AIDS, HIV, Janssen

Johnson &Johnson is entering four new public-private partnerships aimed at significantly reducing the burden of HIV incidence among young girls …
News
robert-horvitz_large_2

PureTech names Nobel Laureate among new members of scientific advisory board

December 1, 2015 Medical Communications, Research and Development PureTech Health, puretech

PureTech Health has compiled a scientific advisory board of distinguished scientists and physicians to expand its senior team.  The scientific …
Appointment
Medicines Patent Pool

Collaboration between MPP and University of Liverpool targets HIV nanomedicines

December 1, 2015 Manufacturing and Production, Research and Development AIDS, HIV, Medicines Patent Pool, antiretrovirals, nanomedicines

The Medicines Patent Pool (MPP) and the University of Liverpool have agreed a partnership to use the university’s solid drug …
News

Laying bare the complexities of the pricing issue

November 30, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, access, affordability, cost of medicines

Richard Bergström, director general of the European Federation of Pharmaceutical Industry and Associations (EFPIA), on why full transparency in cost discussions …
Feature
robert_k

Ablynx appoints Robert Zeldin as new chief medical officer

November 30, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Ablynx, Robert Zeldin

Ablynx has appointed Dr Robert Zeldin as chief medical officer (CMO) effective from 1 December 2015.  Dr Zeldin will lead …
Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026